Balancing personalized medicine and personalized care
- PMID: 23348082
- PMCID: PMC3584182
- DOI: 10.1097/ACM.0b013e3182806345
Balancing personalized medicine and personalized care
Abstract
The current description of personalized medicine by the National Institutes of Health is "the science of individualized prevention and therapy." Although physicians are beginning to see the promise of genetic medicine coming to fruition, the rapid pace of sequencing technology, informatics, and computer science predict a revolution in the ability to care for patients in the near future. The enthusiasm expressed by researchers is well founded, but the expectations voiced by the public do not center on advancing technology. Rather, patients are asking for personalized care: a holistic approach that considers physical, mental, and spiritual well-being. This perspective considers psychological, religious, and ethical challenges that may arise as the precision of preventive medicine improves. Psychological studies already highlight the barriers to single gene testing and suggest significant barriers to the predictive testing envisioned by personalized medicine. Certain religious groups will likely mount opposition if they believe personalized medicine encourages embryo selection. If the technology prompts cost-containment discussions, those concerned about the sanctity of life may raise ethical objections. Consequently, the availability of new scientific developments does not guarantee advances in treatment because patients may prove unwilling to receive and act on personalized genetic information. This perspective highlights current efforts to incorporate personalized medicine and personalized care into the medical curriculum, genetic counseling, and other aspects of clinical practice. Because these efforts are generally independent, the authors offer recommendations for physicians and educators so that personalized medicine can be implemented in a manner that meets patient expectations for personalized care.
Similar articles
-
Person Centered Care and Personalized Medicine: Irreconcilable Opposites or Potential Companions?Health Care Anal. 2019 Mar;27(1):45-59. doi: 10.1007/s10728-017-0347-5. Health Care Anal. 2019. PMID: 28936750
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Personalized medicine, availability, and group disparity: an inquiry into how physicians perceive and rate the elements and barriers of personalized medicine.Public Health Genomics. 2014;17(4):209-20. doi: 10.1159/000362359. Epub 2014 May 21. Public Health Genomics. 2014. PMID: 24852571
-
Personalized medicine in psychiatry: ethical challenges and opportunities.Dialogues Clin Neurosci. 2009;11(4):427-34. doi: 10.31887/DCNS.2009.11.4/kevers. Dialogues Clin Neurosci. 2009. PMID: 20135900 Free PMC article. Review.
-
Personalised Medicine and Medical Imaging: Opportunities and Challenges for Contemporary Health Care.J Med Imaging Radiat Sci. 2018 Dec;49(4):352-359. doi: 10.1016/j.jmir.2018.07.002. Epub 2018 Aug 9. J Med Imaging Radiat Sci. 2018. PMID: 30514550 Review.
Cited by
-
Caring for Pregnant Patients with Cancer: A Framework for Ethical and Patient-Centred Care.Cancers (Basel). 2024 Jan 21;16(2):455. doi: 10.3390/cancers16020455. Cancers (Basel). 2024. PMID: 38275896 Free PMC article. Review.
-
Digital twin for healthcare systems.Front Digit Health. 2023 Sep 7;5:1253050. doi: 10.3389/fdgth.2023.1253050. eCollection 2023. Front Digit Health. 2023. PMID: 37744683 Free PMC article. Review.
-
Clinician perspectives on communication and implementation challenges in precision oncology.Per Med. 2021 Sep;18(6):559-572. doi: 10.2217/pme-2021-0048. Epub 2021 Oct 22. Per Med. 2021. PMID: 34674550 Free PMC article.
-
The Role of Polymorphisms in Collagen-Encoding Genes in Intervertebral Disc Degeneration.Biomolecules. 2021 Aug 26;11(9):1279. doi: 10.3390/biom11091279. Biomolecules. 2021. PMID: 34572492 Free PMC article. Review.
-
In-vivo design feedback and perceived utility of a genetically-informed smoking risk tool among current smokers in the community.BMC Med Genomics. 2021 May 26;14(1):139. doi: 10.1186/s12920-021-00976-1. BMC Med Genomics. 2021. PMID: 34039360 Free PMC article.
References
-
- Chan IS, Ginsburg GS. Personalized Medicine: Progress and Promise. Annual Review of Genomics and Human Genetics. 2011;12:217–244. - PubMed
-
- Dworkin RW. Science, Faith, and Alternative Medicine. Policy Reviews. 2001;108:3–18.
-
- Herper M. Not Quite the $1,000 Genome but Maybe Close Enough. Forbes. 2012
-
- Soverini S, Hochhaus A, Nicolini FE, et al. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European Leukemia Net. Blood. 2011;118:1208–1215. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
